Pfizer’s strategy to delay market share loss to generic Lipitor
(Viewable in full screen 108oi HD) Pharmacist Cynthia Jackevicius of Western University of Health Sciences discusses her New England Journal of Medicine article, co-authored by Harlan Krumholz of Yale...
View ArticleReasons to Abandon Low-Density Lipoprotein Cholesterol Targets
Interviewed by Steven Greer, MD Harlan Krumholz, MD, cardiologist from Yale, discusses his open letter in the journal Circulation recommending that LDL be scrapped as a treatment target for statins.
View ArticleThe false epidemic of autism
Update March 20 , 2013 The annual CDC autism report is out again, misleading the public about a non-epidemic. Update March 29, 2012 The high prevalence of “autism” was in the news again with a CDC...
View ArticleThe Yale led reanalysis of the BMP-2 InFuse trials
Interviewed by Steven E. Greer, MD Medtronic granted rare access to a team led my Yale’s Harlan Krumholz and turned over the complete datasets on 17 InFuse (BMP-2) clinical trials. The goal was to...
View ArticleIndustry conflicts arise at PCORI threatening any real comparative...
February 7, 2014- By Steven E. Greer, MD The Patient Centered Outcome Research Institute (PCORI) was created by the PPACA “ObamaCare” law in 2010. Well-funded with approximately $3 Billion over ten...
View Article
